Product Information
PHENOBARBITAL 32.4 MG TABLET is a generic product labeled by Trigen Laboratories, LLC, priced at $0.0786 per EA under NDC 13811030510. Its NADAC has been published 48 times since Nov 5, 2025.
Strength
32.4 mg/1
Manufacturer
Trigen Laboratories, LLCNDC
13811030510
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
4/1/2025
Price Statistics
The NADAC for PHENOBARBITAL 32.4 MG TABLET has been published 48 times since Nov 5, 2025, and over the history we have for it it has declined 44.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0786 per EA |
|---|---|
| All-time high | $0.1423 (Nov 12, 2025) |
| All-time low | $0.0732 (Jul 22, 2026) |
| 52-week high | $0.1423 |
| 52-week low | $0.0732 |
| Median price | $0.0858 |
| Average price | $0.0940 |
| Largest weekly change | -24.0% (Jan 21, 2026) |
| Weeks tracked | 48 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Trigen Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phenobarbital market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 32.4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 32.4 MG TABLET, manufactured by Trigen Laboratories, LLC, is $0.0786 per EA (NDC 13811030510), effective Sep 30, 2026.
How has the price of PHENOBARBITAL 32.4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 32.4 MG TABLET has declined 44.8%. It has been tracked across 48 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 32.4 MG TABLET?
Since Nov 5, 2025, the NADAC for PHENOBARBITAL 32.4 MG TABLET has ranged from a low of $0.0732 (Jul 22, 2026) to a high of $0.1423 (Nov 12, 2025), with a median of $0.0858 per EA.
Are there cheaper alternatives to PHENOBARBITAL 32.4 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PHENOBARBITAL 32.4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PHENOBARBITAL 32.4 MG TABLET?
PHENOBARBITAL 32.4 MG TABLET (NDC 13811030510) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.